Download PDF Flyer
Impact Factor Current: 2.761
5 - Year: 2.666

CNS & Neurological Disorders - Drug Targets


ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Latest Issue: Volume 18 , Issue 6 , 2019

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.761
5 - Year: 2.666

Ranking & Category

  • 193rd of 261 in Neurosciences
  • 166th of 261 in Pharmacology & Pharmacy

Topics Covered

1 Topics

Covered Diseases

1 Diseases


Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in

Science Citation Index Expanded, Journal Citation Reports/Science Edition, InCites, Current Contents® - Clinical Medicine, Neuroscience Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, PsycINFO, ProQuest, ChemWeb, Google Scholar, MediaFinder®-Standard Periodical Directory, Cabell's Directory, Genamics JournalSeek, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Abstracted/Indexed in

"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Forthcoming Special Issue(s)

Drug Interventions/Therapies for Neural Injury
Guest Editor(s): Kun Xiong
Tentative Publication Date: March, 2020
Submit Abstract via Email

Download Description

Special Issue(s) - In-Press

Brain Imaging and Automatic Analysis in Neurological and Psychiatric diseases
Guest Editor(s): Yu-Dong Zhang, Ti-Fei Yuan, Zheng-Chao Dong
Tentative Publication Date: May, 2016
Submit Abstract via Email

Published Special Issue(s)

Editorial Advisory Board Members Special Issue
Guest Editor(s): Stephen D. Skaper

Download Description

Authors' Comments

I recommend CNS Neurological Disorders & Drug Targets to neuroscientists and practicing neurologists. The papers published on this platform are always of sufficient merit and quality. It maintains the highest standards of peer review, preserving the integrity of science.

Abdelrahman Ibrahim Abushouk
(Faculty of Medicine, Ain Shams University, Cairo, Egypt.)

© 2019 Bentham Science Publishers